Sibannac, Inc. (SNNC) financial statements (2021 and earlier)

Company profile

Business Address 2122 E. HIGHLAND AVENUE, SUITE 425
PHOENIX, AZ 85016
State of Incorp. NV
Fiscal Year End August 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

2/28/2017
Q2
11/30/2016
Q1
8/31/2016
Q4
5/31/2016
Q3
2/29/2016
Q2
11/30/2015
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments12191637110
Cash and cash equivalents12191637110
Receivables012 9190120
Other current assets   32 
Other undisclosed current assets (0)    
Total current assets:12129110129230
Noncurrent Assets
Intangible assets, net (including goodwill)  1191029455
Intangible assets, net (excluding goodwill)  1191029455
Other undisclosed noncurrent assets250250 250250251
Total noncurrent assets:250250119352344306
Other undisclosed assets  195   
TOTAL ASSETS:262262323461473537
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:69631923402
Accounts payable  19   
Interest and dividends payable44  116
Other undisclosed accounts payable and accrued liabilities6559 2329(3)
Debt329313 16265 
Due to related parties1014    
Disposal group, including discontinued operation  346   
Other undisclosed current liabilities   27750260
Total current liabilities:408390366317355262
Noncurrent Liabilities
Liabilities, other than long-term debt250250250250250250
Accounts payable and accrued liabilities250250 250250250
Disposal group, including discontinued operation, liabilities  250   
Total noncurrent liabilities:250250250250250250
Total liabilities:658640616567605512
Stockholders' equity
Stockholders' equity attributable to parent(396)(378)(293)(105)(132)24
Common stock181818181818
Additional paid in capital414141414141
Accumulated deficit(454)(436)(351)(164)(191)(34)
Total stockholders' equity:(396)(378)(293)(105)(132)24
TOTAL LIABILITIES AND EQUITY:262262323461473537

Income statement (P&L) ($ in thousands)

2/28/2017
Q2
11/30/2016
Q1
8/31/2016
Q4
5/31/2016
Q3
2/29/2016
Q2
11/30/2015
Q1
Revenues041(420)89111143
Cost of revenue
(Cost of Goods and Services Sold)
(4)(74) (87)(142)(88)
Other undisclosed gross profit (0)    
Gross profit:(4)(33) 2(30)56
Operating expenses(7)(41)91(41)(119)(85)
Other undisclosed operating income (loss) 0(82)  (4)
Operating income (loss):(11)(74)9(39)(150)(34)
Nonoperating expense
(Other Nonoperating expense)
(7)(10)    
Interest and debt expense(7)(10) (9)(7)(6)
Other undisclosed income from continuing operations before equity method investments, income taxes  21   
Income (loss) from continuing operations:(26)(95)30(48)(156)(39)
Other undisclosed loss before gain (loss) on sale of properties  (218)   
Loss before gain (loss) on sale of properties:(26)(95)(188)(48)(156)(39)
Other undisclosed net income     11
Net loss:(26)(95)(188)(48)(156)(29)
Other undisclosed net income (loss) attributable to parent7101(1)(1)(5)
Net loss available to common stockholders, diluted:(19)(85)(187)(49)(157)(34)

Comprehensive Income ($ in thousands)

2/28/2017
Q2
11/30/2016
Q1
8/31/2016
Q4
5/31/2016
Q3
2/29/2016
Q2
11/30/2015
Q1
Net loss:(26)(95)(188)(48)(156)(29)
Comprehensive loss, net of tax, attributable to parent:(26)(95)(188)(48)(156)(29)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: